HIF1A and colorectal carcinoma: Thereby, the number of viable CRC cells was almost halved with the addition of 20 μM of the HIF-1α inhibitor, and only the addition of 30 μM HIF-1α inhibitor produced a viability-reducing effect comparable to that of 5 μM CA (Figure 1B).